Related Experiment Video
Updated: Oct 22, 2025
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy
Giovanna C N B Lôbo1, Karen L R Paiva1, Ana Luísa G Silva1
1Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.
Abstract:
Cancer, a group of diseases responsible for the second largest cause of global death, is considered one of the main public health problems today. Despite the advances, there are still difficulties in the development of more efficient cancer therapies and fewer adverse effects for the patients. In this context, nanobiotechnology, a materials science on a nanometric scale specified for biology, has been developing and acquiring prominence for the synthesis of nanocarriers that provide a wide surface area in relation to volume, better drug delivery, and a maximization of therapeutic efficiency. Among these carriers, the ones that stand out are those focused on the activation of the immune system. The literature demonstrates the importance of this system for anticancer therapy, given that the best treatment for this disease also activates the immune system to recognize, track, and destroy all remaining tumor cells.
Insights
Nanobiotechnology offers advanced nanocarriers for cancer therapy, enhancing drug delivery and maximizing treatment efficiency. These nanocarriers focus on activating the immune system to effectively target and eliminate tumor cells.
Area of Science:
- Nanobiotechnology and Materials Science
- Cancer Research and Immunology
Background:
- Cancer is a leading global health issue with persistent challenges in developing effective therapies with minimal side effects.
- Nanobiotechnology offers novel solutions through nanocarriers, providing large surface areas for improved drug delivery and therapeutic outcomes.
- Immune system activation is crucial for effective anticancer therapy, enabling the body to recognize and destroy tumor cells.
Purpose of the Study:
- To explore the role of nanobiotechnology in developing advanced nanocarriers for cancer treatment.
- To highlight the significance of nanocarriers that activate the immune system for enhanced anticancer efficacy.
- To underscore the importance of immune system engagement in successful cancer therapy.
Main Methods:
- Review of current literature on nanobiotechnology applications in cancer therapy.
- Analysis of nanocarrier design principles for improved drug delivery and surface area.
- Investigation of immune system activation strategies within nanocarrier-based treatments.
Main Results:
- Nanocarriers synthesized via nanobiotechnology demonstrate superior surface area-to-volume ratios.
- These nanocarriers facilitate enhanced drug delivery, leading to maximized therapeutic efficiency.
- Nanocarriers designed to activate the immune system show significant promise in anticancer strategies.
Conclusions:
- Nanobiotechnology provides innovative nanocarriers that improve cancer treatment efficacy.
- Activating the immune system through nanocarriers is a key strategy for successful cancer therapy.
- Further development in nanobiotechnology holds potential for more effective and targeted cancer treatments.
Related Concept Videos
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...